Literature DB >> 32016127

Cardiovascular Biomarker Profile on Antiretroviral Therapy Is Not Influenced by History of an IRIS Event in People With HIV and Suppressed Viremia.

Aurelie Gouel-Cheron1,2,3, Martha Nason1, Adam Rupert4, Virginia Sheikh5, Greg Robby5, Gary A Fahle6, Irini Sereti5.   

Abstract

Immune reconstitution inflammatory syndrome (IRIS) is characterized by release of proinflammatory cytokines and tissue inflammation occurring early after antiretroviral therapy (ART) initiation. The role of previous IRIS events in persistent chronic inflammation in people with HIV is currently unclear. In this retrospective analysis of 143 participants who maintained suppression of HIV viremia, we compared biomarkers related to inflammation, coagulation, and cardiovascular risk after 3 years on ART in participants with and without a history of IRIS. There was no evidence of higher levels of persistent chronic inflammation in people with HIV who had a history of an IRIS event. ClinicalTrials.gov Identifier . NCT00286767. Published by Oxford University Press on behalf of Infectious Diseases Society of America 2020.

Entities:  

Keywords:  AIDS; HIV infection; biomarkers; cytomegalovirus; immune reconstitution inflammatory syndrome (IRIS); inflammation

Year:  2020        PMID： 32016127      PMCID： PMC6991617          DOI： 10.1093/ofid/ofaa017

Source DB:  PubMed          Journal:  Open Forum Infect Dis        ISSN： 2328-8957            Impact factor:   3.835


  19 in total

Review 1.  Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis.

Authors:  Monika Müller; Simon Wandel; Robert Colebunders; Suzanna Attia; Hansjakob Furrer; Matthias Egger
Journal:  Lancet Infect Dis       Date:  2010-04       Impact factor: 25.071

Review 2.  Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy.

Authors:  J E Kaplan; D Hanson; M S Dworkin; T Frederick; J Bertolli; M L Lindegren; S Holmberg; J L Jones
Journal:  Clin Infect Dis       Date:  2000-04       Impact factor: 9.079

Review 3.  Biomarkers in immune reconstitution inflammatory syndrome: signals from pathogenesis.

Authors:  Irini Sereti; Alison J Rodger; Martyn A French
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

Review 4.  Human Immunodeficiency Virus and Heart Failure in Low- and Middle-Income Countries.

Authors:  Gerald S Bloomfield; Fawaz Alenezi; Felix A Barasa; Rebecca Lumsden; Bongani M Mayosi; Eric J Velazquez
Journal:  JACC Heart Fail       Date:  2015-08       Impact factor: 12.035

5.  Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis.

Authors:  Priscilla Y Hsue; Peter W Hunt; Amanda Schnell; S Craig Kalapus; Rebecca Hoh; Peter Ganz; Jeffrey N Martin; Steven G Deeks
Journal:  AIDS       Date:  2009-06-01       Impact factor: 4.177

Review 6.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

Authors:  Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson
Journal:  Circulation       Date:  2003-10-07       Impact factor: 29.690

7.  Prospective International Study of Incidence and Predictors of Immune Reconstitution Inflammatory Syndrome and Death in People Living With Human Immunodeficiency Virus and Severe Lymphopenia.

Authors:  Irini Sereti; Virginia Sheikh; Douglas Shaffer; Nittaya Phanuphak; Erin Gabriel; Jing Wang; Martha C Nason; Gregg Roby; Hellen Ngeno; Fredrick Kirui; Alice Pau; Joann M Mican; Adam Rupert; Rachel Bishop; Brian Agan; Nitiya Chomchey; Nipat Teeratakulpisarn; Somsit Tansuphaswadikul; Deborah Langat; Josphat Kosgei; Martyn French; Jintanat Ananworanich; Fredrick Sawe
Journal:  Clin Infect Dis       Date:  2020-07-27       Impact factor: 9.079

Review 8.  Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients.

Authors:  Nicholas T Funderburg
Journal:  Curr Opin HIV AIDS       Date:  2014-01       Impact factor: 4.283

9.  Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome.

Authors:  R Tadokera; G Meintjes; K H Skolimowska; K A Wilkinson; K Matthews; R Seldon; N N Chegou; G Maartens; M X Rangaka; K Rebe; G Walzl; R J Wilkinson
Journal:  Eur Respir J       Date:  2010-09-03       Impact factor: 16.671

10.  Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort.

Authors:  I Ratnam; C Chiu; N-B Kandala; P J Easterbrook
Journal:  Clin Infect Dis       Date:  2005-12-28       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.